Weill Cornell Medicine (WCM) neurosurgeons are committed to collaboration with fellow neuroscientists performing translational research, as the infusion of drugs and growth factors hold great promise for neurological disease patients. In addition, new technology using stem cell biology for the treatment of many neurological disorders, including strokes and brain tumors, may provide therapeutic options for our patient population. Our department plays a leading role in the implementation of these new neurological disease treatment paradigms.

Weill Cornell Medicine neurological research facilities include basic and translational laboratories that improve scientific understanding of the central nervous system and hold promise for future treatments.
Weill Cornell Medicine researchers lead the U.S. in clinical trials for neurosurgical conditions. These trials allow us to provide our patients with groundbreaking approaches that improve diagnosis and treatment.
We use innovative research studies to collect data about patients, treatments and outcomes, in order to guide future treatment decisions.
Collaboration is the key to innovation, and WCM neurosurgeons have forged strong collaborative ties with Cornell University's Biomedical Engineering Department in Ithaca.
Endoscopic surgical tools make it possible to capture exquisite details of a procedure. These videos provide a camera's-eye view of endoscopic neurosurgery.
Our faculty and residents produce more than 100 academic papers each year. See a list of some of the most notable publications of the past few years.

Neurological Surgery 525 E. 68th St., Starr 651, Box 99 New York, NY 10065